Regencell Bioscience Holdings Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q3 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.0% | -9.9% | +15.2% | -13.5% | +24.8% | -16.0% | +17.0% | -7.2% | -0.2% | +3.3% | +0.1% | +1.1% | -6.9% | -6.3% | +20.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.7% | -7.1% | +19.2% | +739.7% | +34.1% | -22.2% | +20.3% | -6.2% | +0.8% | -0.6% | -0.7% | +3.0% | -7.9% | -8.4% | +22.2% | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | – | – | +0.0% | – | – | – | – | – | – | – | |
| – | +5.9% | -10.0% | +15.0% | -43.9% | +19.2% | -11.7% | +15.0% | -7.8% | -0.8% | +5.8% | +0.7% | -0.1% | -6.3% | -5.1% | +19.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.2% | +0.0% | +31.2% | +0.0% | -27.1% | +0.0% | +503.6% | +200,000.4% | -99.9% | +199,998.9% | -100.0% | +199,999.0% | -100.0% | +199,995.7% | -99.9% | +0.0% | +20.0% | +0.0% | +87,157.0% | +100.0% | -13.1% | -5.6% | |
| – | -1.6% | -5.5% | +16.8% | +505.4% | +2.9% | -2.8% | +6.0% | -0.8% | -1.2% | +0.5% | +0.5% | +0.0% | -17.5% | +19.7% | +1.5% | -100.0% | +0.0% | +96.9% | +0.0% | -44.4% | +0.0% | +619.1% | +0.0% | +206.8% | +200,634.2% | -100.0% | +185,689.6% | -99.9% | +209,896.4% | -99.9% | +176,946.8% | -100.0% | +0.0% | -14.1% | +29.6% | +75,837.1% | +100.5% | -7.9% | – | |
| – | +2.5% | -5.6% | +16.1% | +16.2% | +4.2% | -0.9% | +6.4% | -4.9% | +0.8% | +3.4% | +1.5% | -3.2% | +2.4% | +0.4% | +5.4% | -100.0% | +0.0% | +72.6% | +0.0% | -35.1% | +0.0% | +203.4% | +0.0% | +261.2% | +200,004.7% | -99.9% | +170,461.8% | -100.0% | +206,894.2% | -100.0% | +151,029.4% | -99.9% | +0.0% | +4.9% | +0.0% | +81,493.9% | +100.0% | -9.4% | +195.7% | |
| – | +22.0% | -31.7% | +56.5% | -43.0% | +127.7% | -47.7% | +69.0% | -19.4% | -8.0% | +17.8% | -3.0% | +14.6% | -41.1% | -42.9% | +187.5% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9,266.7% | -21.0% | +74.3% | -50.5% | +128.5% | -58.5% | +151.2% | -22.8% | -20.3% | +27.5% | +17.1% | -5.5% | -47.4% | -42.3% | +188.3% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1,078.9% | -19.6% | +72.8% | -50.8% | +123.5% | -57.9% | +151.4% | -18.0% | -24.2% | +29.8% | +2.1% | +3.0% | -41.4% | -30.0% | +219.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -21.0% | +73.4% | -50.1% | +131.2% | -59.0% | +151.1% | -26.0% | -17.7% | +26.3% | +27.4% | -10.2% | -51.2% | -51.7% | +153.5% | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +103.4% | -9.8% | +34.5% | -29.6% | +52.9% | -37.1% | +65.0% | -14.2% | -10.5% | +15.1% | +10.2% | -2.3% | -25.4% | -17.3% | +53.6% | -100.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.